Related references
Note: Only part of the references are listed.Unlocking the Mystery of the Therapeutic Effects of Chinese Medicine on Cancer
Shao-Hsiang Liu et al.
FRONTIERS IN PHARMACOLOGY (2021)
Comparative Efficacy and Safety of Chinese Herbal Injections Combined With Cyclophosphamide and 5-Fluorouracil Chemotherapies in Treatment of Breast Cancer: A Bayesian Network Meta-Analysis
Shuyu Liu et al.
FRONTIERS IN PHARMACOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Investigation on the Efficiency of Chinese Herbal Injections for Treating Non-small Cell Lung Cancer With Vinorelbine and Cisplatin Based on Multidimensional Bayesian Network Meta-Analysis
Mengwei Ni et al.
FRONTIERS IN PHARMACOLOGY (2021)
Clinical Application of Chinese Herbal Injection for Cancer Care: Evidence-Mapping of the Systematic Reviews, Meta-analyses, and Randomized Controlled Trials
Ming Yang et al.
FRONTIERS IN PHARMACOLOGY (2021)
Medicinal herbs and bioactive compounds overcome the drug resistance to epidermal growth factor receptor inhibitors in non-small cell lung cancer
Hiu Yan Jennifer Lee et al.
ONCOLOGY LETTERS (2021)
The effect of kanglaite injection in combination with gefitinib versus gefitinib alone in patients with nonsmall cell lung cancer: A meta-analysis
He Hailang et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2020)
Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study
Yukio Hosomi et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Kanglaite Injection Combined with Chemotherapy versus Chemotherapy Alone for the Improvement of Clinical Efficacy and Immune Function in Patients with Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
Jianxia Wen et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)
Kanglaite injection plus platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A meta-analysis of 27 RCTs
Xiaoming Huang et al.
PHYTOMEDICINE (2020)
Efficacy and safety of Kanglaite injection combined with first-line platinum-based chemotherapy in patients with advanced NSCLC: a systematic review and meta-analysis of 32 RCTs
Juan Li et al.
ANNALS OF PALLIATIVE MEDICINE (2020)
Combination of traditional Chinese medicine and epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of non-small cell lung cancer A systematic review and meta-analysis
Xinbing Sui et al.
MEDICINE (2020)
Aidi Injection, Compound Kushen Injection, or Kanglaite Injection: Which Is the Best Partner with Systemic Chemotherapy for Patients with HCC? A Network Meta-Analysis
Dou Dou et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)
Efficacy and safety of Kanglaite injection combined with chemotherapy for colorectal cancer A protocol for systematic review and meta-analysis
Weili Mao et al.
MEDICINE (2020)
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
Yuening Xiang et al.
CANCER MEDICINE (2019)
Chinese Herbal Medicine Combined With EGFR-TKI in EGFR Mutation-Positive Advanced Pulmonary Adenocarcinoma (CATLA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Lijing Jiao et al.
FRONTIERS IN PHARMACOLOGY (2019)
The clinical efficacy and safety of kanglaite adjuvant therapy in the treatment of advanced hepatocellular carcinoma: a PRISMA-compliant meta-analysis
Jingjing Liu et al.
BIOSCIENCE REPORTS (2019)
Traditional Chinese Medicine Proton vs Progression-Free Survival and Enhances Therapeutic Effects in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Treated Non-Small-Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations
Mo Tang et al.
MEDICAL SCIENCE MONITOR (2019)
Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Oncology
Rashmi R. Shah et al.
DRUG SAFETY (2019)
Effects of Kanglaite Injection on Serum miRNA-21 in Patients with Advanced Lung Cancer
Yue Wu et al.
MEDICAL SCIENCE MONITOR (2018)
Molecular inhibition mechanisms of cell migration and invasion by coix polysaccharides in A549 NSCLC cells via targeting S100A4
Cheng Luo et al.
MOLECULAR MEDICINE REPORTS (2017)
Lung cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study
Thomas B. Richards et al.
CANCER (2017)
Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations
Jun Wang et al.
ONCOTARGETS AND THERAPY (2016)
Prediction of Overall Survival or Progression Free Survival by Disease Control Rate at Week 8 Is Independent of Ethnicity: Western Versus Chinese Patients With First-Line Non-Small Cell Lung Cancer Treated With Chemotherapy With or Without Bevacizumab
Laurent Claret et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
A polysaccharide fraction of adlay seed (Coix lachryma-jobi L.) induces apoptosis in human non-small cell lung cancer A549 cells
Xiangyi Lu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Antitumor activity and immunomodulatory effects of the intraperitoneal administration of Kanglaite in vivo in Lewis lung carcinoma
Pei Pan et al.
JOURNAL OF ETHNOPHARMACOLOGY (2012)
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell et al.
LANCET ONCOLOGY (2012)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Share Paper
